Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA9 | Q16790 | 3/20 | 0.43 |
| ▸ | PYGB | P11216 | 7/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29439292 | 1.00 | CA12 (0.43) | CA12CA1CA2CA9PYGB | |
| SCHEMBL26135776 | 1.00 | CA12 (0.43) | CA12CA1CA2CA9PYGB | |
| SCHEMBL31150424 | 1.00 | CA12 (0.43) | CA12CA1CA2CA9PYGB | |
| SCHEMBL20265935 | 1.00 | CA12 (0.43) | CA12CA1CA2CA9PYGB | |
| SCHEMBL28448246 | 0.83 | CA12 (0.44) | CA12CA1CA2CA9PYGB | |
| SCHEMBL28444663 | 0.83 | CA12 (0.44) | CA12CA1CA2CA9PYGB | |
| SCHEMBL734876 | 0.83 | CA12 (0.44) | CA12CA1CA2CA9PYGB | |
| SCHEMBL28448523 | 0.83 | CA12 (0.44) | CA12CA1CA2CA9PYGB | |
| SCHEMBL9346601 | 0.81 | CA12 (0.42) | CA12CA1CA2CA9PYGB | |
| SCHEMBL28732847 | 0.81 | PYGB (0.48) | CA12CA1CA2CA9PYGB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12590117-B2 | Hexose derivatives, preparation and uses thereof | FACULDADE DE CIENCIAS DA UNIVERSIDADE DE LISBOA (PT) | 2026-03-31 | — | — | US | disclosed |
| US-20230357301-A1 | HEXOSE DERIVATIVES, PREPARATION AND USES THEREOF | FACULDADE DE CIENCIAS DA UNIVERSIDADE DE LISBOA (PT) | 2023-11-09 | — | — | US | disclosed |
| US-11708387-B2 | Hexose derivatives, preparation and uses thereof | FACULDADE DE CIÊNCIAS DA UNIVERSIDADE DE LISBOA (PT) | 2023-07-25 | — | — | US | disclosed |
| CN-115448964-A | Hexose derivatives and their formulations and use | 里斯本大学科学与技术学院 | 2022-12-09 | — | — | CN | disclosed |
| EP-1420806-B1 | ANTIBODY DETECTION METHOD USING TRIPLE POLYPEPTIDE COMPLEXES DERIVED FROM COLLAGEN II | HOLMDAHL RIKARD (SE) | 2013-05-01 | — | — | EP | disclosed |
| US-20090176714-A1 | METHOD OF REDUCING THE EFFECTS OF ABeta AND COMPOSITIONS THEREFORE | JOHNSON JEFFREY A | 2009-07-09 | — | — | US | disclosed |
| US-20070161545-A1 | Triple polypeptide complexes | AREXIS AB, A SWEDEN CORPORATION | 2007-07-12 | — | — | US | disclosed |
| US-7148020-B2 | Triple polypeptide complexes | AREXIS AB (SE) | 2006-12-12 | — | — | US | disclosed |
| US-20060122120-A1 | Method of reducing the effects of Abeta and compositions therefore | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-06-08 | — | — | US | disclosed |
| EP-1420806-A2 | TRIPLE POLYPEPTIDE COMPLEXES | Arexis AB (SE) | 2004-05-26 | — | — | EP | disclosed |
| US-20030148944-A1 | Triple polypeptide complexes | AREXIS AB (SE) | 2003-08-07 | — | — | US | disclosed |
| WO-2003006603-A2 | TRIPLE POLYPEPTIDE COMPLEXES | AREXIS AB (SE) | 2003-01-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357301-A1 | HEXOSE DERIVATIVES, PREPARATION AND USES THEREOF | HK1, SLC5A1, HK2 | CA12 598/4885CA1 745/4885CA2 901/4885 |
| US-12590117-B2 | Hexose derivatives, preparation and uses thereof | SLC5A1, HK1, SLC5A2 | CA12 442/4885CA1 383/4885CA2 325/4885 |
| US-11708387-B2 | Hexose derivatives, preparation and uses thereof | HK1, SLC5A1, HK2 | CA12 598/4885CA1 745/4885CA2 901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.